Florida2nd Congressional District

The bill expands access to integrated primary and behavioral health care for Medicaid beneficiaries and strengthens reimbursement for safety‑net providers, while increasing Medicaid costs, imposing implementation burdens on states/providers, and creating some risk of overbilling without additional safeguards.

1. house
3. senate
5. president

The bill aims to improve patient safety and transparency by creating an LDT-specific regulatory regime and public database while imposing substantial new compliance obligations and legal complexity that could raise costs for labs, disadvantage smaller providers, and risk service disruptions during the transition.

1. house
3. senate
5. president

The bill speeds and increases transparency of Medicare local coverage decisions and adds a review path—improving timeliness and stakeholder input—but raises risks of rushed or lower-quality decisions, added administrative costs, privacy exposure, and narrower evidence acceptance that could delay coverage for novel therapies.

1. house
3. senate
5. president

The bill separates high-cost outpatient cancer drugs from bundled payments to improve transparency and provider reimbursement and protect access, but it risks higher patient cost-sharing, payment shifts within the outpatient fee schedule, and greater administrative and short-term payment uncertainty.

1. house
3. senate
5. president

The bill provides formal recognition for victims’ families and a pathway for public purchase of commemorative duplicates while structuring the program to recover costs through Mint sales, at the expense of modest administrative burdens, potential higher prices for buyers, and some loss of budgetary transparency and flexibility.

1. house
3. senate
5. president

The bill substantially expands access to psychiatric and other controlled medications via telehealth and simplifies cross‑state practice—improving timely care for many patients—while imposing federal standards and provider requirements that raise costs, reduce state/local control, and heighten risks of diversion and uneven protections unless monitoring and enforcement are strengthened.

1. house
3. senate
5. president

The bill strengthens parents’ technical control over minors’ direct messaging and preserves strong encryption and privacy, but it raises privacy trade‑offs from expanded age‑detection, imposes compliance costs, delays some protections, and centralizes enforcement at the federal level—trading faster, local innovation and certain investigative tools for standardized, privacy‑preserving child‑safety rules.

1. house
3. senate
5. president

The bill expands guaranteed dental and vision coverage and federal oversight for Medicaid enrollees with sickle cell disease—improving care access and accountability—while increasing state Medicaid costs, adding reporting obligations, and leaving non‑Medicaid patients without the new benefits.

1. house
3. senate
5. president

The bill expands access to long‑acting injectable medications, related services, and clinician training—improving treatment capacity and transparency—while raising federal costs, adding reporting burdens, and risking diversion of resources from other treatment options.

1. house
3. senate
5. president